Wall Street is positive on Arena Pharmaceuticals, Inc. (ARNA). On average, analysts give the stock a Strong Buy rating. The average price target is $97.428, which means analysts expect the stock to add by 64.27% over the next twelve months. That average ranking earns the stock an Analyst Rating of 75, which is better than 75% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating ARNA a Strong Buy today. Find out what this means to you and get the rest of the rankings on ARNA!